Healthcare
26 February 2018
Analysis: GV exits Flatiron Health
US-based oncology research technology provider Flatiron Health became the latest of GV’s life sciences-focused exits, after a $1.9bn acquisition by pharmaceutical firm Roche.
Pharmaceutical firm Roche agreed to acquire cancer research technology provider Flatiron Health, paying $1.9bn for the remainder of the company’s shares, giving GV, the corporate venturing unit of internet conglomerate Alphabet, its fifth latest life sciences exit since November. At the time of the acquisition, Roche already owned a…Read More.
12 February 2018
Analysis: Ping An Ventures to raise $1.3bn
Ping An Ventures, the corporate venturing unit of China-based insurance group Ping An, is currently seeking to raise $1.3bn in capital for two healthcare-oriented funds. Both funds will invest at growth…
22 January 2018
Analysis: Celgene impacts Sanofi in a billion-dollar exit
Pharmaceutical company Sanofi is to exit cancer treatment developer Impact Biomedicines, which was acquired by fellow pharmaceutical firm Celgene for $1.1bn up. The transaction is comprised of Celgene…
- 11 December 2017 – Big Deal: Cell Design acquisition shows immunotherapies sector success
- 11 September 2017 – Analysis: NeoTract to be acquired for $1.1bn
- 13 September 2016 – Summer slowdown
- 22 August 2016 – Fund in the News: DigiTx Partners
- 3 August 2016 – Big Deal: GSK seeks truth with Alphabet
- 21 July 2016 – Corporate venture changeover in healthcare
- 20 June 2016 – Fund in the News: Robert Bosch Venture Capital
- 9 June 2016 – Record year for life sciences
- 9 June 2016 – Profile: Johnson & Johnson
- 5 April 2016 – Interview: Deutsche Telekom Capital Partners’ Jack Young
- 7 March 2016 – Fund in the News: Pierre Fabre Fund for Innovation
- 29 February 2016 – Interview: Healthcare VC and exits compress as the market speeds up
- 22 February 2016 – Interview: Healthcare funding in 2015 reaches new heights
- 18 June 2015 – Healthcare proves an attractive proposition
